Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,965 total articles
Westwood Holdings Group announced the launch of the Westwood Salient Enhanced Power & Infrastructure ETF (PWRX) on the Texas Stock Exchange, marking the first new ETF debut on this platform. Scheduled for September 17, 2026, PWRX is an actively managed ETF targeting income and growth opportunities within the evolving energy market, including tradit…
Streamex Corp., a US-based technology company listed on NASDAQ, announced its participation as an Innovator Partner at the 2026 Real-World Asset Summit in Brooklyn. CEO Henry McPhie will join a panel discussing the tokenization of commodities, highlighting Streamex's role in developing institutional-grade blockchain solutions for commodity markets.…
Magnite released new research revealing that live streaming engages audiences beyond main events, with viewers increasingly co-watching and interacting with pre- and post-event content. The study highlights that Connected TV (CTV) amplifies live content reach, and advertising in these live and surrounding streams boosts consumer purchase intent. St…
Exyn Technologies has appointed Ben Williams as interim CEO and Gregory McNeal as Chairman of the Board following the resignation of the prior CEO. Both leaders bring extensive military and defense industry experience to drive the company's expansion into defense and national security sectors. The company emphasizes its advanced autonomous mapping …
Foresight Autonomous Holdings Ltd. and VisionWave Holdings, Inc. have entered a strategic cooperation agreement to develop advanced AI-enabled autonomous unmanned ground vehicles (UGVs) for defense applications. The collaboration combines Foresight's stereoscopic 3D perception and infrared sensing technology with VisionWave's VARAN™ autonomous UGV …
Baosheng Group (NASDAQ: BAOS) has entered a strategic cooperation memorandum of understanding with 58.com Group to advance AI technologies in marketing, advertising, and local services. The collaboration aims to integrate Baosheng's AI virtual human, media-buying, and content capabilities with 58.com's local offline resources to create innovative '…
Lands' End, Inc. announced it will hold a conference call on September 3, 2026, to discuss its second quarter fiscal 2026 financial results. The company will issue a news release beforehand and provide live and archived broadcasts on its investor relations website.
Autozi Internet Technology (Global) Ltd. announced ongoing discussions with multiple investors to secure approximately $55 million in additional financing following a recent $30 million investment. The funds will support the company's expansion in automotive supply-chain integration, development of cross-border platforms, enhancement of digital and…
InflaRx N.V., a biopharmaceutical company specializing in anti-inflammatory therapies targeting the complement system, announced its participation in two major investor conferences in September 2026. The company will deliver presentations and conduct investor meetings detailing advances in its lead programs, izicopan and vilobelimab, targeting C5a …
BOS Better Online Solutions Ltd. reported a significant 29% year-over-year revenue increase in Q2 2026, driven by growth in its RFID division. Despite a soft first half revenue performance roughly matching last year, the company's strong backlog of $31 million and raised net income guidance reflect optimistic future prospects. BOS experienced curre…
Cerenome, Inc. announced new pharmacokinetic, dosimetry, safety, and activity data for its therapeutic REYOBIQ in leptomeningeal metastases patients, alongside economic analysis showing CNSide diagnostics can significantly reduce treatment costs. The data supports the company's integrated CNS oncology platform combining diagnostics, targeted therap…
Advasa Holdings, Inc., a fintech payment holding company operating through its Japanese subsidiary, announced a revised date for the commencement of trading its common stock on the Nasdaq Global Market. Originally expected to begin on August 18, 2026, trading is now anticipated to start on August 25, 2026, to allow completion of standard administra…
Flyte, a subsidiary of Catheter Precision, Inc., announced surpassing 10,000 consumer accounts on its private aviation WebApp, with new account creation accelerating significantly in August 2026. The platform's user base spans 174 airports across 19 states, reflecting strong demand and effective customer acquisition through technology and strategic…
Evaxion A/S, a Nasdaq-listed TechBio company, announced its Q2 2026 financial results and provided a business update highlighting advancements in its AI-Immunology™ platform-driven vaccine pipeline. The company is preparing to present important clinical data for its personalized cancer vaccine EVX-01 and is progressing with novel off-the-shelf canc…
Cytokinetics announced upcoming presentations at the European Society of Cardiology Congress highlighting positive topline results from the ACACIA-HCM Phase 3 trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy. The company plans to discuss these results with regulatory authorities and hosted an investor event to elabora…
Navios Maritime Partners L.P. reported record financial results for Q2 and H1 2026 with significant revenue and net income growth driven by higher charter rates and operational efficiency. The company declared a $0.06 quarterly distribution and announced a new $200 million common unit repurchase program. Fleet expansion continued with acquisitions …
Flash Sports & Media Holdings, a Nasdaq-listed cricket media and sports entertainment company, has signed an agreement to become the official title sponsor of the Swiss National Cricket Men’s Team. The sponsorship involves branding rights on team clothing, matchday and venue signage, digital placements, and content production for Flash’s streaming …
The Honest Company announced its participation in the Barclays 19th Annual Global Consumer Conference and the Wells Fargo 9th Annual Consumer Conference, held in September 2026. The company, known for cleanly-formulated and sustainably-designed personal care products, aims to engage with investors and discuss its mission and business performance.
Radiopharm Theranostics received a positive recommendation from the Data Safety and Monitoring Committee to advance its Phase 1 clinical trial of 177Lu-RAD202 to a higher dose level of 180mCi in patients with HER2-positive advanced solid tumors. This advancement follows encouraging safety and biodistribution results in earlier cohorts, marking prog…
AC Immune announced promising preliminary Phase 1 clinical trial results for ACI-19764, an orally available NLRP3 inflammasome inhibitor targeting chronic inflammation in neurodegenerative and metabolic diseases. The drug was safe, well tolerated, showed confirmed brain penetration, and displayed pharmacodynamics consistent with target engagement. …
Harrow announced positive results from a prospective, randomized study demonstrating that their ophthalmic gel, IHEEZO® (chloroprocaine hydrochloride 3%), significantly reduces patient-reported discomfort following intravitreal injections compared to proparacaine 0.5%. The study, involving 50 patients undergoing bilateral same-day injections, showe…
Tilray Brands, Inc. has significantly expanded its global medical cannabis cultivation capacity from 210 to approximately 275 metric tonnes annually, enhancing supply from its Quebec and EU-GMP-certified Portugal facilities. This expansion strengthens Tilray's leadership in key international medical cannabis markets including Canada, Europe, Austra…
NovaBridge Biosciences reported its first half 2026 financial results showing increased R&D and administrative expenses reflecting advancement of its pipeline. The company announced key clinical milestones including plans to start a registrational Phase 3 study of givastomig by year-end 2026 under a potential FDA Accelerated Approval Pathway and pr…
UroGen Pharma Ltd. announced a strategic collaboration and equity investment in IntraGel Therapeutics to access its proprietary biodegradable sustained-release gel platform (SRGel). This agreement grants UroGen research licensing and exclusive options to develop up to three novel oncology products, along with an exclusive option to commercialize Tu…
ARRAY Technologies held its APA Investor Technology Showcase to detail its strategy to evolve from a tracker-only company into a fully integrated energy infrastructure platform, highlighting progress with APA Solar integration, growth opportunities, and the pending acquisition of Affordable Wire Management to expand into solar infrastructure compon…
